1. Home
  2. PAYC vs PTGX Comparison

PAYC vs PTGX Comparison

Compare PAYC & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paycom Software Inc.

PAYC

Paycom Software Inc.

HOLD

Current Price

$123.57

Market Cap

6.3B

Sector

Technology

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$114.79

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAYC
PTGX
Founded
1998
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.4B
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
PAYC
PTGX
Price
$123.57
$114.79
Analyst Decision
Buy
Strong Buy
Analyst Count
15
13
Target Price
$168.79
$108.23
AVG Volume (30 Days)
840.1K
612.0K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
1.17%
N/A
EPS Growth
N/A
N/A
EPS
3.04
0.05
Revenue
$433,047,000.00
N/A
Revenue This Year
$8.79
$874.25
Revenue Next Year
$7.48
N/A
P/E Ratio
$41.08
$2,257.20
Revenue Growth
N/A
N/A
52 Week Low
$104.90
$49.86
52 Week High
$248.95
$114.49

Technical Indicators

Market Signals
Indicator
PAYC
PTGX
Relative Strength Index (RSI) 38.42 66.80
Support Level $118.80 $94.48
Resistance Level $126.91 N/A
Average True Range (ATR) 5.31 4.72
MACD -1.86 1.46
Stochastic Oscillator 15.00 100.00

Price Performance

Historical Comparison
PAYC
PTGX

About PAYC Paycom Software Inc.

Paycom is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. The firm's solutions are available on a unified, modular platform, and customers are billed for access on a subscription basis. Paycom's customer base skews toward the midmarket and is primarily based in North America. As of 2025, the firm manages records for 7.4 million employees across more than 20,000 clients on a parent-company-group basis.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: